NYSE:BDXA
Delisted

Becton Dickinson and Co Depositary ETF News

$59.24
+0 (+0%)
At Close: Sep 04, 2020
Becton Dickinson said on Thursday that it will increase domestic production of medical syringes.
Becton, Dickinson and Company (BD) experienced weak growth in China, with a decline of 5.3% year-over-year. BD's major challenges, including the Alaris pump and Covid comparisons, are starting to norm
Becton Dickinson beat first-quarter profit estimates and raised its full-year earnings forecast on Thursday as it benefits from strong demand for its surgical equipment.
Becton, Dickinson and Company has underperformed the market and healthcare sector in recent years. The company's balance sheet has improved significantly which I believe will allow for increased retur
Becton Dickinson Chairman, President and CEO Tom Polen joins 'Mad Money' host Jim Cramer to talk inflation's impact on healthcare, the prefilled syringe market and more.
Becton Dickinson Chairman, President and CEO Tom Polen joins 'Mad Money' host Jim Cramer to talk inflation's impact on healthcare, the prefilled syringe market and more.
Becton Dickinson said on Thursday the U.S. Food and Drug Administration (FDA) had cleared its less invasive blood collection device.
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
Becton, Dickinson, and Company is a healthcare company with strong fundamentals and a history of dividend growth. The company has shown robust execution of its 2025 strategy, positioning it for sustai
U.S. equities fell midday ahead of comments from Fed Chair Jerome Powell that could offer clues about the future of monetary policy. The Dow, S&P 500, and Nasdaq were all lower.
Visa and Exxon Mobil announced dividend increases in October, with Visa increasing its dividend by 15.6% and Exxon Mobil increasing its dividend by 4.4%. Several companies, including AbbVie, American

Becton, Dickinson Stock Is A Hold, Here's Why

06:25pm, Wednesday, 04'th Oct 2023
Becton, Dickinson and Company is a global healthcare company specializing in medical supplies, devices, and diagnostic products. BDX saw solid growth in Q3 driven by strong demand for pharmacy automat
Becton Dickinson beat Wall Street estimates for third-quarter profit on Thursday, helped by strong demand for its drug delivery devices and surgical equipment.
Shares of Becton Dickinson rose to their highest level since 2020 after the FDA gave 501(k) clearance to Becton Dickinson's updated BD Alaris Infusion System.
Shares of Becton Dickinson hit an all-time high on Monday and were last up 6.1% after the medical device maker received U.S. Food and Drug Administration clearance late on Friday for the market return
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE